Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Neuropathic pain, dysautonomia, and nerve hyperexcitability: Expanding the spectrum of LGI1 autoimmunity.

Berzero G, Lenglet T, Giry M, d'Anglejan J, Joubert B, Cohen F, Psimaras D.

Clin Neurophysiol. 2019 Feb;130(2):248-250. doi: 10.1016/j.clinph.2018.11.017. Epub 2018 Dec 7. No abstract available.

PMID:
30583271
2.

A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas.

Rosenberg S, Simeonova I, Bielle F, Verreault M, Bance B, Le Roux I, Daniau M, Nadaradjane A, Gleize V, Paris S, Marie Y, Giry M, Polivka M, Figarella-Branger D, Aubriot-Lorton MH, Villa C, Vasiljevic A, Lechapt-Zalcman E, Kalamarides M, Sharif A, Mokhtari K, Pagnotta SM, Iavarone A, Lasorella A, Huillard E, Sanson M.

Nat Commun. 2018 Jun 18;9(1):2371. doi: 10.1038/s41467-018-04622-w.

3.

Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.

Vialatte de Pémille C, Berzero G, Small M, Psimaras D, Giry M, Daniau M, Sanson M, Delattre JY, Honnorat J, Desestret V, Alentorn A.

Br J Cancer. 2018 Jul;119(1):105-113. doi: 10.1038/s41416-018-0125-7. Epub 2018 Jun 14.

4.

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.

Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T, Bielle F, Cazals-Hatem D, Varlet P, Figarella-Branger D, Loiseau H, Kalamarides M.

Neuro Oncol. 2018 Jul 5;20(8):1113-1121. doi: 10.1093/neuonc/nox231.

5.

Progestin-associated shift of meningioma mutational landscape.

Peyre M, Gaillard S, de Marcellus C, Giry M, Bielle F, Villa C, Boch AL, Loiseau H, Baussart B, Cazabat L, Raffin-Sanson ML, Sanson M, Kalamarides M.

Ann Oncol. 2018 Mar 1;29(3):681-686. doi: 10.1093/annonc/mdx763.

PMID:
29206892
6.

Diffuse gliomas with FGFR3-TACC3 fusion have characteristic histopathological and molecular features.

Bielle F, Di Stefano AL, Meyronet D, Picca A, Villa C, Bernier M, Schmitt Y, Giry M, Rousseau A, Figarella-Branger D, Maurage CA, Uro-Coste E, Lasorella A, Iavarone A, Sanson M, Mokhtari K.

Brain Pathol. 2018 Sep;28(5):674-683. doi: 10.1111/bpa.12563. Epub 2017 Nov 21.

PMID:
28976058
7.

EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco.

Senhaji N, Louati S, Chbani L, El Fatemi H, Hammas N, Mikou K, Maaroufi M, Benzagmout M, Boujraf S, El Bardai S, Giry M, Marie Y, Chaoui El Faiz M, Mokhtari K, Idbaih A, Amarti A, Bennis S.

Biomed Res Int. 2017;2017:8045859. doi: 10.1155/2017/8045859. Epub 2017 Jul 13.

8.

Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co-deleted anaplastic gliomas.

Bielle F, Ducray F, Mokhtari K, Dehais C, Adle-Biassette H, Carpentier C, Chanut A, Polivka M, Poggioli S, Rosenberg S, Giry M, Marie Y, Duyckaerts C, Sanson M, Figarella-Branger D, Idbaih A; Pola Network.

Brain Pathol. 2017 Sep;27(5):567-579. doi: 10.1111/bpa.12434. Epub 2016 Oct 28.

PMID:
27543943
9.

Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas.

Labussière M, Rahimian A, Giry M, Boisselier B, Schmitt Y, Polivka M, Mokhtari K, Delattre JY, Idbaih A, Labreche K, Alentorn A, Sanson M.

Oncologist. 2016 Sep;21(9):1131-5. doi: 10.1634/theoncologist.2016-0003. Epub 2016 Jul 8.

10.

K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway.

Joyon N, Tauziède-Espariat A, Alentorn A, Giry M, Castel D, Capelle L, Zanello M, Varlet P, Bielle F.

Neuropathol Appl Neurobiol. 2017 Apr;43(3):271-276. doi: 10.1111/nan.12329. No abstract available.

PMID:
27219822
11.

Acceptability of antibiotic stewardship measures in primary care.

Giry M, Pulcini C, Rabaud C, Boivin JM, Mauffrey V, Birgé J.

Med Mal Infect. 2016 Sep;46(6):276-84. doi: 10.1016/j.medmal.2016.02.001. Epub 2016 Apr 4.

PMID:
27056661
12.

TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.

Nencha U, Rahimian A, Giry M, Sechi A, Mokhtari K, Polivka M, Schmitt Y, Di Stefano AL, Alentorn A, Labussière M, Sanson M.

J Neurooncol. 2016 Feb;126(3):441-6. doi: 10.1007/s11060-015-1999-3. Epub 2015 Nov 25.

PMID:
26608520
13.

Chordoid gliomas of the third ventricle share TTF-1 expression with organum vasculosum of the lamina terminalis.

Bielle F, Villa C, Giry M, Bergemer-Fouquet AM, Polivka M, Vasiljevic A, Aubriot-Lorton MH, Bernier M, Lechapt-Zalcman E, Viennet G, Sazdovitch V, Duyckaerts C, Sanson M, Figarella-Branger D, Mokhtari K; RENOP.

Am J Surg Pathol. 2015 Jul;39(7):948-56. doi: 10.1097/PAS.0000000000000421.

PMID:
25786084
14.

Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma.

Di Stefano AL, Fucci A, Frattini V, Labussiere M, Mokhtari K, Zoppoli P, Marie Y, Bruno A, Boisselier B, Giry M, Savatovsky J, Touat M, Belaid H, Kamoun A, Idbaih A, Houillier C, Luo FR, Soria JC, Tabernero J, Eoli M, Paterra R, Yip S, Petrecca K, Chan JA, Finocchiaro G, Lasorella A, Sanson M, Iavarone A.

Clin Cancer Res. 2015 Jul 15;21(14):3307-17. doi: 10.1158/1078-0432.CCR-14-2199. Epub 2015 Jan 21.

15.

TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.

Labussière M, Di Stefano AL, Gleize V, Boisselier B, Giry M, Mangesius S, Bruno A, Paterra R, Marie Y, Rahimian A, Finocchiaro G, Houlston RS, Hoang-Xuan K, Idbaih A, Delattre JY, Mokhtari K, Sanson M.

Br J Cancer. 2014 Nov 11;111(10):2024-32. doi: 10.1038/bjc.2014.538. Epub 2014 Oct 14.

16.

Molecular analysis of diffuse intrinsic brainstem gliomas in adults.

Reyes-Botero G, Giry M, Mokhtari K, Labussière M, Idbaih A, Delattre JY, Laigle-Donadey F, Sanson M.

J Neurooncol. 2014 Jan;116(2):405-11. doi: 10.1007/s11060-013-1312-2. Epub 2013 Nov 17.

PMID:
24242757
17.

Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.

Alentorn A, Marie Y, Carpentier C, Boisselier B, Giry M, Labussière M, Mokhtari K, Hoang-Xuan K, Sanson M, Delattre JY, Idbaih A.

Neuro Oncol. 2012 Nov;14(11):1393-403. doi: 10.1093/neuonc/nos217. Epub 2012 Oct 16. Erratum in: Neuro Oncol. 2013 Mar;15(3):403.

18.

Rho prevents apoptosis through Bcl-2 expression: implications for interleukin-2 receptor signal transduction.

Gómez J, Martínez C, Giry M, García A, Rebollo A.

Eur J Immunol. 1997 Nov;27(11):2793-9.

PMID:
9394801
19.

Rho-dependent membrane folding causes Shigella entry into epithelial cells.

Adam T, Giry M, Boquet P, Sansonetti P.

EMBO J. 1996 Jul 1;15(13):3315-21.

20.

Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation.

Popoff MR, Chaves-Olarte E, Lemichez E, von Eichel-Streiber C, Thelestam M, Chardin P, Cussac D, Antonny B, Chavrier P, Flatau G, Giry M, de Gunzburg J, Boquet P.

J Biol Chem. 1996 Apr 26;271(17):10217-24.

21.

Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia.

Nusrat A, Giry M, Turner JR, Colgan SP, Parkos CA, Carnes D, Lemichez E, Boquet P, Madara JL.

Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10629-33.

23.

Inhibition of p21 Rho in intact cells by C3 diphtheria toxin chimera proteins.

Boquet P, Popoff MR, Giry M, Lemichez E, Bergez-Aullo P.

Methods Enzymol. 1995;256:297-306. No abstract available.

PMID:
7476444
24.

Clostridium difficile toxin B acts on the GTP-binding protein Rho.

Just I, Fritz G, Aktories K, Giry M, Popoff MR, Boquet P, Hegenbarth S, von Eichel-Streiber C.

J Biol Chem. 1994 Apr 8;269(14):10706-12.

25.

Supplemental Content

Support Center